Abstract
In July of this year, a new team of editors will assume leadership of Circulation . We follow in the footsteps of visionary leaders in our field who have established and fostered a journal of impeccable reputation. Our team has been afforded the opportunity to capitalize on the richness and remarkable strengths of Circulation , indeed the entire portfolio of Circulation journals. Our profession—and I personally—owe a sincere debt of gratitude to Dr Joseph Loscalzo, his team of editors, and the editors who preceded them. Looking to the future, cardiovascular science and medicine face a wide range of challenges and unprecedented opportunities. In Circulation , we will bring robust energy and dedication to our opportunity to help shape the future of cardiovascular medicine. We have conceived a model that is innovative and novel, one in which we capitalize on changes in cardiovascular disease, cardiovascular science, technology, and more. Just as heart disease, vascular disease, and stroke are evolving, so will we. As technological advances proliferate, we will evolve in innovative ways to capitalize on those advances. Circulation will be innovative, and we will not be afraid to experiment. We will launch bold initiatives, and we hope that many of them will succeed. Likely, some will fail. These “experiments” in medical publishing will be coupled with …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
